Latest news
AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile - MorningstarMorningstar · Mon, 10 Aug 2026 11:00:00 GMTVerified Clinical Trials Partners with WindRose Health Investors to Accelerate Growth and Welcomes Howard Miller as Chief Executive Officer - MorningstarMorningstar · Thu, 06 Aug 2026 11:08:00 GMTHaut.AI Launches AI-Powered Clinical Studies Software for Large-Scale Skin Studies Across Clinic, Hybrid, and At-Home Environments - MorningstarMorningstar · Tue, 04 Aug 2026 12:00:00 GMT